Liucan Wang

742 citations
18 papers · 638 indexed · h-index 13
Topics
Nanoparticle-Based Drug Delivery (7 papers)Nanoplatforms for cancer theranostics (5 papers)Dendrimers and Hyperbranched Polymers (3 papers)
Partner nations
ChinaThailandGermany

In The Last Decade

Liucan Wang

18 papers receiving 630 citations

Peers

Liucan Wang
Comparison fields: 5 of 88
  • Biomedical Engineering 345
  • Biomaterials 218
  • Materials Chemistry 193
  • Molecular Biology 179
  • Surfaces, Coatings and Films 61
Replace Nathan Stasko with:
Nathan Stasko United States
Haoqi Tan China
Xiaoshuang Guo China
Tangjian Cheng China
Guangyue Zu China
Italo Rodrigo Calori Brazil
Renjith P. Johnson South Korea
Zhenzhen Weng China
Jingli Ren China
Liucan Wang relative to Nathan Stasko United States Nathan Stasko's profile →
Citations per field
00.5×3.4×
Nathan Stasko · 1×
Citations per year

Countries citing papers authored by Liucan Wang

Since Specialization
Citations

This map shows the geographic impact of Liucan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liucan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liucan Wang more than expected).

Fields of papers citing papers by Liucan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liucan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liucan Wang. The network helps show where Liucan Wang may publish in the future.

Co-authorship network of co-authors of Liucan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liucan Wang. A scholar is included among the top collaborators of Liucan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liucan Wang. Liucan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 3
2 6
3 5
4 8
5 43
6 15
7 12
8 62
9 95
10 33
11 63
12 83
13 80
14 42
15 13
16 51
17 8
18 16

About Liucan Wang

Liucan Wang is a scholar working on Biomaterials, Surfaces, Coatings and Films and Polymers and Plastics, having authored 18 papers that have together received 638 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (5 papers) and Dendrimers and Hyperbranched Polymers (3 papers). The work is most often cited by research in Biomaterials (218 citations), Surfaces, Coatings and Films (61 citations) and Biomedical Engineering (345 citations). Liucan Wang has collaborated with scholars based in China, Thailand and Germany. Frequent co-authors include Jixi Zhang, Yuxin Xing, Kaiyong Cai, Zhenqiang Wang, Tao Ding, Lu Wang, Neeraj Prabhakar, Jessica M. Rosenholm, Peng Liu and Jia Tang. Their work appears in journals such as Advanced Functional Materials, ACS Applied Materials & Interfaces and Journal of Colloid and Interface Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026